Synthesis and biological evaluation of a novel 99mTc(CO) 3 complex of ciprofloxacin dithiocarbamate as a potential agent to target infection

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 12, 2010, Pages 3781-3784

  Zhang, Junbo ^a   Zhang, Shijian ^a   Guo, Haixun ^a   Wang, Xuebin ^a  

^a BEIJING NORMAL UNIVERSITY   (China)

Author keywords

99mTc tricarbonyl complex; Ciprofloxacin; Dithiocarbamate; Infection imaging

Indexed keywords

CARBON TRIOXIDE TC 99M; CIPROFLOXACIN; CIPROFLOXACIN DITHIOCARBAMATE; RADIOISOTOPE; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ABSCESS; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFECTION; LEG MUSCLE; LIPOPHILICITY; MALE; MOUSE; NONHUMAN; RABBIT; SERUM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYNTHESIS; THIGH;

ANIMALS; BACTERIAL ADHESION; BLOOD; CIPROFLOXACIN; DRUG STABILITY; INFECTION; MICE; MUSCLE, SKELETAL; ORGANOTECHNETIUM COMPOUNDS; RABBITS; RADIOPHARMACEUTICALS; THIOCARBAMATES; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

BACTERIA (MICROORGANISMS); MUS; ORYCTOLAGUS CUNICULUS;

EID: 77954213335     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.04.057     Document Type: Article

References (16)

1. F. Gemmel, N. Dumarey, and M. Welling Semin. Nucl. Med. 39 2009 11
2. K.E. Britton, S. Vinjamuri, A.V. Hall, K.K. Solanki, J. Bomanji, and S. Das Eur. J. Nucl. Med. 24 1997 553
3. S. Vinjamuri, A.V. Hall, K.K. Solanki, J. Bomanji, Q. Siraj, E. O'Shaughnessy, E.E. Das, and K.E. Britton Lancet 347 1996 233
4. A.V. Hall, K.K. Solanki, S. Vinjamuri, K.E. Britton, and S.J. Das Clin. Pathol. 51 1998 215
5. K.E. Britton, D.W. Wareham, S. Das, K.K. Solanki, H. Amaral, A. Bhatnagar, A.H.S. Katamihardja, J. Malamitsi, H.M. Moustafa, V.E. Soroa, F.X. Sundram, and A.K.J. Padhy Clin. Pathol. 55 2002 817
6. R.H. Siaens, J.H. Rennen, O.C. Boerman, R. Dierckx, and G.J. Slegers Nucl. Med. 45 2004 2088
7. S.J. Oh, J. Ryu, J.W. Shin, E.J. Yoon, H. Ha, J.H. Cheon, and H.K. Lee Appl. Radiat. Isot. 57 2002 193
8. D. Rodríguez-Puig, C. Piera, D. Fuster, A. Soriano, J.M. Sierra, S. Rubí, and J.J. Suades J. Labelled Compd. Radiopharm. 49 2006 1171
9. J.B. Zhang, H.X. Guo, S.J. Zhang, Y. Lin, and X.B. Wang Bioorg. Med. Chem. Lett. 18 2008 5168
10. R. Alberto, R. Schibli, A. Egli, P.A. Schubiger, U. Abram, and T.A. Kaden J. Am. Chem. Soc. 120 1998 7987
11. R. Alberto, K. Ortner, N. Wheatley, R. Schibli, and P.A. Schubiger J. Am. Chem. Soc. 123 2001 3135
12. Y. Jiang, and B.L. Liu Chin. Sci. Bull. 46 2001 727
13. J.C. Wang, B.L. Liu, H.Z. Mi, Y. Jiang, Z.G. Tang, and H.M. Gui Chin. J. Nucl. Med. 22 2002 231
14. 3-CPFXDTC complex was characterized by HPLC. HPLC analysis was carried out with a reversed-phase column (Kromasil 100-5C, 250 × 4.6 mm), Shimadzu SCL-10AVP series, working at a flow rate of 1.0 mL/min. Water (A) and methanol (B) mixtures were used as the mobile phase and the following gradient elution technique was adopted for the preparation (0 min 70% B, 10 min 70% B, 15 min 90% B, 30 min 90% B).
15. 99mTc. The measurements were repeated three times and reported as an average of three measurements plus the standard deviation.
16. H. Zhang, N.Y. Jiang, L. Zhu, H.Y. Li, X.Y. Liu, G.B. Chen, and S.X. Chen J. Chin. Clin. Med. Imaging 17 2006 42